Pharmacokinetic and Pharmacodynamic Interactions Between Henagliflozin, a Novel Selective SGLT-2 Inhibitor, and Warfarin in Healthy Chinese Subjects
- Resource Type
- Article
- Source
- In
Clinical Therapeutics July 2023 45(7):655-661 - Subject
- Language
- ISSN
- 0149-2918